Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: Case report and literature review

Journal of Cutaneous Medicine and Surgery

Volumn 16, Issue 6, 2012, Pages 458-461

  Binamer, Yousef ^a   Sowerby, Laura ^a   El Helou, Therese ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; MINOCYCLINE; PSEUDOMONIC ACID; TACROLIMUS;

ADULT; AGED; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG EFFICACY; EPITHELIZATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NECROBIOSIS LIPOIDICA; PRIORITY JOURNAL; RECURRENT INFECTION; RELAPSE; SCAR; SKIN BIOPSY; SKIN INDURATION; SKIN ULCER; TREATMENT DURATION; TREATMENT FAILURE; ULCERATIVE NECROBIOSIS LIPOIDICA; WOUND CARE; WOUND DRESSING; WOUND INFECTION;

ADMINISTRATION, CUTANEOUS; ADULT; AGED, 80 AND OVER; CALCINEURIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NECROBIOSIS LIPOIDICA; SKIN ULCER; TACROLIMUS;

EID: 84872363759     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347541201600621     Document Type: Article

References (42)

1. Oppenheim A. Ber eine bisher nicht beschriebene, mit eigentümlicher lipoider Degeneration der Elastica und des Bindegewebes einhergehende Dermatose bei Diabetes Mellitus. Arch Derm Syph 1932;166:576-83, doi:10.1007/BF02071265.
2. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum. Arch Dermatol 1966;93:273-81, doi:10.1001/archderm.1966.01600210008002.
3. Gottrup F, Karlsmark T. Leg ulcers: uncommon presentations. Clin Dermatol 2005;23:601-11, doi:10.1016/j.clindermatol.2005.01.018. (Pubitemid 41743799)
4. Kukreja T, Petersen J. Thalidomide for the treatment of refractory necrobiosis lipoidica. Arch Dermatol 2006;142:20-2, doi:10.1001/archderm.142.1. 20. (Pubitemid 43107355)
5. Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol 1991;25(5 Pt 1):735-48, doi:10.1016/S0190-9622(08)80961-9.
6. De Rie MA, Sommer A, Hoekzema R, Neumann HA. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002;147:743-7, doi:10.1046/j.1365-2133.2002.04856.x. (Pubitemid 35286161)
7. Ngo BT, Hayes KD, DiMiao DJ, et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005;6:225-37, doi:10.2165/00128071- 200506040-00003. (Pubitemid 41159409)
8. Hammami H, Youssef S, Jaber K, et al. Perforating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: a new case reported. Dermatol Online J 2008;14(7):11.
9. Kreuter A, Knierim C, Stücker M, et al. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br J Dermatol 2005;153:802-7, doi:10.1111/j.1365-2133.2005.06762.x. (Pubitemid 41415909)
10. Tidman MJ, Duncan C. The treatment of necrobiosis lipoidica. Br J Diabetes Vasc Dis 2005;5:37-41, doi:10.1177/14746514050050010701. (Pubitemid 40352808)
11. Howard A, White CR. Non-infectious granulomas. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 1st ed. Philadelphia: Mosby; 2003. p. 1455-69.
12. Goldstein BG, Goldstein AO. Practical dermatology. St. Louis (MO): Mosby-Year Book Inc; 1997.
13. Burns M, Hausein U. Generalized destructive, ulcerating and debilitating necrobiosis lipoidica sine diabetes in a young male recalcitrant to therapy. J Eur Acad Dermatol Venereol 1997;8:236-40.
14. Köstler E, Wollina U. Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA. Int J Low Extrem Wounds 2003;2:243-5, doi:10.1177/1534734603260680.
15. Gkdemir G, Sakiz D, Kşlü A. Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: diagnostic and therapeutic challenge. J Turk Acad Dermatol 2008;2:82101c.
16. Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking and proteinuria. A case controlled study. Diabet Med 1993;10:725, doi:10.1111/j.1464-5491.1993. tb00155.x.
17. Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr Dermatol 1995;12:220, doi:10.1111/j.1525-1470.1995. tb00162.x.
18. Imtiaz KE, Khaleeli AA. Squamous cell carcinoma developing in necrobiosis lipoidica. Diabet Med 2001;18:325-8, doi:10.1046/j.1464-5491.2001.00452.x. (Pubitemid 32579364)
19. Kossard S, Collins E, Wargon O, Downie D. Squamous carcinomas developing in bilateral lesions of necrobiosis lipoidica. Australas J Dermatol 1987;28:14-7, doi:10.1111/j.1440-0960.1987.tb00321.x. (Pubitemid 18000034)
20. Lim C, Tschuchnigg M, Lim J. Squamous cell carcinoma arising in an area of long-standing necrobiosis lipoidica. J Cutan Pathol 2006;33:581-3, doi:10.1111/j.1600-0560.2006.00487.x. (Pubitemid 44213861)
21. Narbutt J, Torzecka JD, Sysa-Jedrzejowska A, Zalewska A. Long-term results of topical PUVA in necrobiosis lipoidica. Clin Exp Dermatol 2006;31:65-7, doi:10.1111/j.1365-2230.2005.01962.x.
22. Breuer K, Gutzmer R, Völker B, et al. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters. Br J Dermatol 2005;152:1290-5, doi:10.1111/j.1365-2133.2005.06585.x. (Pubitemid 40933431)
23. Handfield-Jones S, Jones S, Peachey R. High dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol 1988;118:693-6, doi:10.1111/j.1365-2133.1988.tb02572.x.
24. Zeichner JA, Stern DW, Lebwohl M. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006;54(3 Suppl 2):S120-1, doi:10.1016/j.jaad.2005.11.1042. (Pubitemid 43243483)
25. Nguyen K, Washenik K, Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol 2002;46(2 Suppl Case Reports):S34-6, doi:10.1016/S0190-9622(02)70230-2.
26. Durupt F, Dalle S, Debarbieux S, et al. Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol 2008;144:118-9, doi:10.1001/archderm.144.1.118. (Pubitemid 351159406)
27. Heidenheim M, Jemec GB. Successful treatment of necrobiosis lipoidica diabeticorum with photodynamic therapy. Arch Dermatol 2006;142:1548-50, doi:10.1001/archderm.142.12.1548. (Pubitemid 44969209)
28. Berking C, Hegyi J, Arenberger P, et al. Photodynamic therapy of necrobiosis lipoidica - a multicenter study of 18 patients. Dermatology 2009;218:136-9, doi:10.1159/000182259.
29. De Giorgi V, Buggiani G, Rossi R, et al. Successful topical photodynamic treatment of refractory necrobiosis lipoidica. Photodermatol Photoimmunol Photomed 2008;24:332-3, doi:10.1111/j.1600-0781.2008.00390.x.
30. Noz KC, Korstanje MJ, Vermeer BJ. Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline. Clin Exp Dermatol 1993;18:78-9, doi:10.1111/j.1365-2230.1993.tb00977.x. (Pubitemid 23043858)
31. Heng MC, Song MK, Heng MK. Healing of necrobiotic ulcers with antiplatelet therapy. Correlation with plasma thromboxane levels. Int J Dermatol 1989;28:195-7, doi:10.1111/j.1365-4362.1989.tb02465.x. (Pubitemid 19114138)
32. Dwyer CM, Dick D. Ulceration in necrobiosis lipoidica - a case report and study. Clin Exp Dermatol 1993;18:366-9, doi:10.1111/j.1365-2230.1993.tb02220.x. (Pubitemid 23212839)
33. Kolde G, Muche JM, Schulze P, et al. Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica. Dermatology 2003;206:180-1, doi:10.1159/000068465. (Pubitemid 36205293)
34. Hu SW, Bevona C, Winterfield L, et al. Treatment of refractory necrobiosis lipoidica diabeticorum with infliximab: report of a case. Arch Dermatol 2009;145:437-9, doi:10.1001/archdermatol.2009.6.
35. Remes K, Rönnemaa T. Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment. J Diabetes Complications 1999;13:115-8, doi:10.1016/S1056- 8727(98)00025-7. (Pubitemid 29320018)
36. Darvay A, Acland KM, Russell-Jones R. Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol 1999;141:725-7, doi:10.1046/j.1365-2133.1999.03119.x. (Pubitemid 29512831)
37. Stinco G, Parlangeli ME, De Francesco V, et al. Ulcerated necrobiosis lipoidica treated with cyclosporin A. Acta Derm Venereol 2003;83:151-3, doi:10.1080/00015550310007616. (Pubitemid 36433970)
38. Stanway A, Rademaker M, Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol 2004;45:119-22, doi:10.1111/j.1440-0960.2004.00059.x. (Pubitemid 38607926)
39. Hanke CW, Bergfeld WF. Treatment with benzoyl peroxide of ulcers on legs within lesions of necrobiosis lipoidica diabeticorum. J Dermatol Surg Oncol 1978;4:701-4. (Pubitemid 9028450)
40. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 2005;152:581-2, doi:10.1111/j.1365-2133.2005.06388.x. (Pubitemid 40547144)
41. Patsatsi A, Kyriakou A, Sotiriadis D. Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus. Case Rep Dermatol 2011;3:89-93, doi:10.1159/000327936.
42. Weinstein DA, Kirsner RS. Refractory ulcers: the role of tumor necrosis factor-alpha. J Am Acad Dermatol 2010;63:146-54, doi:10.1016/j.jaad.2009.08.004.